Charcot M, 1868, Gazette Hôpitaux, 141, 554
National Multiple Sclerosis Society. Frequently asked questions about multiple sclerosis. New York, NY: National Multiple Sclerosis Society; 2013. http://www.nationalmssociety.org/about- multiple-sclerosis/what-we-know-about-ms/faqs-about-ms/index.aspx
National Multiple Sclerosis Society. For people with relapsing MS. New York, NY: National Multiple Sclerosis Society; 2013. http://www.nationalmssociety.org/about-multiple-sclerosis/relapsing-ms/index.aspx
Babbe H, 2000, J Exp Med, 192, 393, 10.1084/jem.192.3.393
Saxena A, 2011, FEBS Lett, 585, 3758, 10.1016/j.febslet.2011.08.047
10.1212/01.wnl.0000275229.13012.32
10.1016/S0022-510X(02)00069-2
Gourraud PA, 2012, Immunol Rev, 248, 87, 10.1111/j.1600-065X.2012.01134.x
Hafler DA, 2007, N Engl J Med, 357, 851, 10.1056/NEJMoa073493
Gregory SG, 2007, Nat Genet, 39, 1083, 10.1038/ng2103
Lundmark F, 2007, Nat Genet, 39, 1108, 10.1038/ng2106
Sospedra M, 2005, Annu Rev Immunol, 23, 683, 10.1146/annurev.immunol.23.021704.115707
Robertson NP, 1996, Neurology, 47, 347, 10.1212/WNL.47.2.347
Gilden DH., 1999, Ann Neurol, 46, 4, 10.1002/1531-8249(199907)46:1<4::AID-ANA3>3.0.CO;2-V
Kurtzke JF, 1993, Clin Microbiol Rev, 6, 382, 10.1128/CMR.6.4.382
Libbey JE, 2010, Results Probl Cell Differ, 51, 21, 10.1007/400_2008_12
Kurtzke JF, 2001, J Clin Epidemiol, 54, 1, 10.1016/S0895-4356(00)00268-7
Kurtzke JF. The epidemiology of multiple sclerosis. In: Raine CS, McFarland HF, Tourtellotte WW, editors. Multiple sclerosis: clinical and pathogenetic basis. London: Chapman & Hall; c1997. pp. 91–140.
Poskanzer DC, 1963, Lancet, 2, 917, 10.1016/S0140-6736(63)90624-X
Poskanzer DC, 1963, Trans Am Neurol Assoc, 88, 253
Poskanzer DC, 1966, Acta Neurol Scand, 42, 85
Leibowitz U, 1966, J Neurol Neurosurg Psychiatry, 29, 60, 10.1136/jnnp.29.1.60
Bach JF, 2002, N Engl J Med, 347, 911, 10.1056/NEJMra020100
Tauber SC, 2007, Arch Physiol Biochem, 113, 124, 10.1080/13813450701531227
Murta V, 2013, Mol Cell Neurosci, 53, 6, 10.1016/j.mcn.2012.06.004
Casserly G, 2007, Neurol.Sci., 253, 48, 10.1016/j.jns.2006.11.017
Abramovitz P, 1987, J Infect Dis, 155, 482, 10.1093/infdis/155.3.482
Lindsey J, 2008, Mult Scler, 14, 147, 10.1177/1352458507082149
Bahar M, 2012, J Pak Med Assoc, 62, S6-S8
Sriram S, 1999, Ann Neurol, 46, 6, 10.1002/1531-8249(199907)46:1<6::AID-ANA4>3.0.CO;2-M
Fainardi E, 2009, J Neuro Virol, 15, 425
Bagos PG, 2006, Mult Scler, 12, 397, 10.1191/1352458506ms1291oa
Krone B, 2008, Mult Scler, 14, 136, 10.1177/1352458507082069
10.1097/00005072-199606000-00001
Torres BA, 2001, Exp Biol Med, 226, 164, 10.1177/153537020122600303
Fritz RB, 1983, J Immunol, 130, 1024, 10.4049/jimmunol.130.3.1024
Soos JM, 2002, J Neuroimmunol, 123, 30, 10.1016/S0165-5728(01)00476-3
Tuohy VK, 1998, Immunol Rev, 164, 93, 10.1111/j.1600-065X.1998.tb01211.x
Mulvey MR, 2011, Mult Scler, 17, 397, 10.1177/1352458510391343
Libbey JE, Fujinami RS. Viral demyelinating disease in experimental animals. In: Herndon RM editor. Multiple sclerosis: immunology, pathology and pathophysiology. New York: Demos; c2003. pp. 125–133.
Power C, 2010, Can J Neurol Sci, 37, S24, 10.1017/S031716710002240X
Tselis A, 2011, Semin Neurol, 31, 307, 10.1055/s-0031-1287656
Virtanen JO, 2012, CNS Neurol Disord Drug Targets, 11, 528, 10.2174/187152712801661220
Johnson RT. Viral infections of the nervous system. 2nd ed. Philadelphia: Lippincott-Raven; c1998.
Kakalacheva K, 2011, Biochim Biophys Acta, 1812, 132, 10.1016/j.bbadis.2010.06.012
Haahr S, 2006, Rev Med Virol, 16, 297, 10.1002/rmv.503
Thacker EL, 2006, Ann Neurol, 59, 499, 10.1002/ana.20820
Handel AE, 2010, PLoS One, 5, e12496, 10.1371/journal.pone.0012496
Disanto G, 2013, Mult Scler
Levin LI, 2005, JAMA, 293, 2496, 10.1001/jama.293.20.2496
Lunemann JD, 2006, Brain, 129, 1493, 10.1093/brain/awl067
Holmoy T, 2004, J Neuro Virol, 10, 278
Oikonen M, 2011, Mult Scler, 17, 672, 10.1177/1352458510394397
Virtanen JO, 2007, J Neuro Virol, 13, 347
Derfuss T, 2005, J Neurol, 252, 968, 10.1007/s00415-005-0794-z
Challoner PB, 1995, Proc Natl Acad Sci USA, 92, 7440, 10.1073/pnas.92.16.7440
Fotheringham J, 2005, Herpes, 12, 4
Tejada-Simon MV, 2003, Ann Neurol, 53, 189, 10.1002/ana.10425
Cirone M, 2002, J Med Virol, 68, 268, 10.1002/jmv.10190
Álvarez-Lafuente R, 2004, Arch Neurol, 61, 1523, 10.1001/archneur.61.10.1523
Simpson S, 2012, Mult Scler, 18, 799, 10.1177/1352458511428081
Perron H, 2009, J Neurol Sci, 286, 65, 10.1016/j.jns.2009.04.034
Christensen T, 2010, J Neuroimmune Pharmacol, 5, 326, 10.1007/s11481-010-9214-y
Perron H, 2010, Clin Rev Allergy Immunol, 39, 51, 10.1007/s12016-009-8170-x
Balada E, 2010, Int Rev Immunol, 29, 351, 10.3109/08830185.2010.485333
Antony JM, 2011, Biochim Biophys Acta, 1812, 162, 10.1016/j.bbadis.2010.07.016
Lander ES, 2001, Nature, 409, 860, 10.1038/35057062
Perron H, 1997, Proc Natl Acad Sci USA, 94, 7583, 10.1073/pnas.94.14.7583
Perron H, 2001, Virology, 287, 321, 10.1006/viro.2001.1045
Perron H, 2012, Mult Scler, 18, 1721, 10.1177/1352458512441381
Garcia-Montojo M, 2013, PLoS One, 8, e53623, 10.1371/journal.pone.0053623
Petersen T, 2009, J Neuroimmunol, 215, 108, 10.1016/j.jneuroim.2009.08.015
Antony JM, 2007, J Immunol, 179, 1210, 10.4049/jimmunol.179.2.1210
Nexø BA, 2011, PLoS One, 6, e16652, 10.1371/journal.pone.0016652
Laska MJ, 2012, J Virol, 86, 3713, 10.1128/JVI.06723-11
Martinelli-Boneschi F, 2012, Mult Scler, 18, 1384, 10.1177/1352458512439118
Massilamany C, 2010, J Neuroimmunol, 219, 17, 10.1016/j.jneuroim.2009.11.006
Massilamany C, 2011, Int Immunol, 23, 729, 10.1093/intimm/dxr084
10.4049/jimmunol.180.9.6402
Angelucci F, 2005, Dis Markers, 21, 49, 10.1155/2005/826817
Ngono AE,, 2012, Clin Immunol, 144, 117, 10.1016/j.clim.2012.05.009
Reindl M, 2006, J Neuroimmunol, 180, 50, 10.1016/j.jneuroim.2006.06.028
Castro GA. Helminths: structure, classification, growth, and development. In: Baron S, editor. Medical microbiology. 4th ed. Galveston: University of Texas Medical Branch at Galveston; c1996.
Yazdanbakhsh M, 2002, Science, 296, 490, 10.1126/science.296.5567.490
Sewell D, 2003, Int Immunol, 15, 59, 10.1093/intimm/dxg012
La Flamme AC, 2003, Infect Immun, 71, 4996, 10.1128/IAI.71.9.4996-5004.2003
Walsh KP, 2009, J Immunol, 183, 1577, 10.4049/jimmunol.0803803
Fleming JO, 2006, Neurology, 67, 2085, 10.1212/01.wnl.0000247663.40297.2d
Cabre P, 2005, Brain, 128, 2899, 10.1093/brain/awh624
Correale J, 2007, Ann Neurol, 61, 97, 10.1002/ana.21067
Correale J, 2008, Ann Neurol, 64, 187, 10.1002/ana.21438
Correale J, 2011, J Neuroimmunol, 233, 6, 10.1016/j.jneuroim.2011.01.002
Correale J, 2011, Mult Scler, 17, 1162, 10.1177/1352458511418027
Fleming JO, 2011, Mult.Scler., 17, 743, 10.1177/1352458511398054
Durelli L, 2002, Neurol Sci, 23, S39, 10.1007/s100720200014
Yanagisawa C, 2007, J Infect Chemother, 13, 368, 10.1007/s10156-007-0551-6
Jorgensen SH, 2005, J Neurol Sci, 233, 61, 10.1016/j.jns.2005.03.005
Rodriguez M, 1990, Ann Neurol, 27, 12, 10.1002/ana.410270104
Jorgensen SH, 2005, Neurol Res, 27, 591, 10.1179/016164105X48798
Fazekas F, 2007, J Neurol Sci, 259, 61, 10.1016/j.jns.2006.12.018
Bayry J, 2009, Nat Rev Drug Discov, 8, 594, 10.1038/nrd2358-c1
Krone B, 2010, Autoimmune Dis, 2011, 708750
Ascherio A, 2000, Epidemiology, 11, 220, 10.1097/00001648-200003000-00023
Weidenmaier C, 2012, Trends Microbiol, 20, 243, 10.1016/j.tim.2012.03.004
Brindley N, 2009, Exp Parasitol, 121, 254, 10.1016/j.exppara.2008.11.009
World Health Organization. Soil-transmitted helminth infections. Geneva: World Health Organization; 2012. http://www.who.int/mediacentre/factsheets/fs366/en/
von Herrath MG, 2003, Nat Rev Microbiol, 1, 151, 10.1038/nrmicro754
Santón A, 2011, Mult Scler, 17, 1295, 10.1177/1352458511411063
Brudek T, 2007, J Neuroimmunol, 187, 147, 10.1016/j.jneuroim.2007.04.003
Mameli G, 2012, PLoS One, 7, e44991, 10.1371/journal.pone.0044991
Tai AK, 2008, Mult Scler, 14, 1175, 10.1177/1352458508094641
Tai AK, 2009, J Clin Virol, 46, 47, 10.1016/j.jcv.2009.05.019
